Cryptococcosis: Difference between revisions
(Text replacement - "==References== " to "==References== <references/> ") |
|||
| (9 intermediate revisions by 5 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Can produce focal cerebral lesions or diffuse meningoencephalitis | *Can produce focal cerebral lesions or diffuse [[meningoencephalitis]] | ||
==Clinical Features== | ==Clinical Features== | ||
*[[Fever]] | |||
*[[Headache]] | |||
*[[Nausea]] | |||
*[[altered mental status]] | |||
*[[Focal neurologic deficits]] | |||
*Meningismus is uncommon | |||
==Diagnosis== | ==Differential Diagnosis== | ||
{{Headache DDX}} | |||
==Evaluation== | |||
*Neuroimaging usually normal | *Neuroimaging usually normal | ||
*'''CSF Studies''' | *'''CSF Studies''' | ||
| Line 20: | Line 24: | ||
**Cryptococcal antigen testing (95% Sn) | **Cryptococcal antigen testing (95% Sn) | ||
== | ==Management== | ||
{{Cryptococcus | {{Cryptococcus Pneumonia}} | ||
{{Cryptococcus Meningitis}} | {{Cryptococcus Meningitis}} | ||
| Line 29: | Line 33: | ||
*Some patients can require longer durations of therapy depending on symptom persistence | *Some patients can require longer durations of therapy depending on symptom persistence | ||
== | ==See Also== | ||
* | *[[Fungal infections]] | ||
==References== | |||
<references/> | |||
[[Category:ID]] | [[Category:ID]] | ||
Latest revision as of 01:13, 24 July 2017
Background
- Can produce focal cerebral lesions or diffuse meningoencephalitis
Clinical Features
- Fever
- Headache
- Nausea
- altered mental status
- Focal neurologic deficits
- Meningismus is uncommon
Differential Diagnosis
Headache
Common
Killers
- Meningitis/encephalitis
- Myocardial ischemia
- Retropharyngeal abscess
- Intracranial Hemorrhage (ICH)
- SAH / sentinel bleed
- Acute obstructive hydrocephalus
- Space occupying lesions
- CVA
- Carbon monoxide poisoning
- Basilar artery dissection
- Preeclampsia
- Cerebral venous thrombosis
- Hypertensive emergency
- Depression
Maimers
- Giant cell arteritis of temporal artery (temporal arteritis)
- Idiopathic intracranial hypertension (Pseudotumor Cerebri)
- Acute Glaucoma
- Acute sinusitis
- Cavernous sinus thrombosis or cerebral sinus thrombosis
- Carotid artery dissection
Others
- Mild traumatic brain injury
- Trigeminal neuralgia
- TMJ pain
- Post-lumbar puncture headache
- Dehydration
- Analgesia abuse
- Various ocular and dental problems
- Herpes zoster ophthalmicus
- Herpes zoster oticus
- Cryptococcosis
- Febrile headache (e.g. pyelonephritis, nonspecific viral infection)
- Ophthalmoplegic migraine
- Superior Vena Cava Syndrome
Aseptic Meningitis
- Viral
- Tuberculosis
- Lyme disease
- Syphilis
- Leptospirosis
- Fungal (AIDS, transplant, chemotherapy, chronic steroid use)
- Noninfectious
Evaluation
- Neuroimaging usually normal
- CSF Studies
- Crypto antigen (100% Sn & Sp)
- Crypto culture (95%-100% Sn)
- India Ink (60-80% Sn)
- Opening pressure
- Usually elevated; drain CSF until pressure is <20 or 50% of opening presure
- Serum
- Cryptococcal antigen testing (95% Sn)
Management
Pulmonary (not AIDS associated)
- Fluconazole 400mg PO IV q24hrs x 6-12 months OR
- Itraconazole 200mg PO q12hrs daily x 6-12 months OR
- Voriconazole 200mg PO q12hrs x 6-12 months
Pulmonary (with AIDS)
- Fluconazole 400mg PO q24hrs x 6-12 months
Meningitis (not AIDs associated)
- Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 4 weeks
- Followed by Fluconazole 400mg PO q24hrs x 8 weeks
Meningitis (with AIDS)
- Amphotericin B 0.7-1mg/kg IV q24hrs AND Flucytosine 25mg/kg PO q6hrs x 2 weeks
- Followed by Fluconazole 400mg PO q24hrs x 8 weeks
- Initiation of HAART is delayed by 2 to 10 weeks to minimize the risk of immune reconstitution syndrome
Disposition
- Admit to Medicine with ID consult
- Once the CD4 count > 200 and the patient is asymptomatic therapy x 6 months, therapy can be discontinued
- Some patients can require longer durations of therapy depending on symptom persistence